Newsroom

Sorted by: Latest

-

HuLoop Reports Strong H1 2026 Growth as Banks, Credit Unions and Retailers Embrace a Blended Human, Robotic and Agentic Workforce

AUBURN, Calif.--(BUSINESS WIRE)--HuLoop Automation, a leader in AI-powered work optimization, today announced strong first-half 2026 growth, adding 28 new customers across banking, credit unions and retail operations. The momentum reflects growing demand from organizations looking to reimagine how work gets done in the AI era by orchestrating and harmonizing Human Workers, Robotic Workers and Agentic Workers across their operations. The growth is supported by expansion of HuLoop's product and o...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 05.08.2026 FAPR.LN IE000WX2HZQ7  250,002.00 USD   6,532,610.71   26.130  ...
-

Insight Enterprises, Inc. Reports Second Quarter Results

CHANDLER, Ariz.--(BUSINESS WIRE)--Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) today reported financial results for the quarter ended June 30, 2026. Highlights include: Consolidated net sales increased 15% year over year Gross profit increased 18% year over year to $521.6 million and gross margin expanded 60 basis points to 21.7% Consolidated net earnings increased 65% year over year to $77.6 million Adjusted earnings before interest, tax, depreciation and amortization (“EBITDA”) in...
-

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Results Total revenue of $29.1 million, compared with $24.2 million in the second quarter of 2025 HEPZATO KIT™ revenue of $27.1 million, compared to $22.5 million in the second quarter of 2025...
-

Ralph Lauren Reports Better Than Expected First Quarter Fiscal 2027 Results and Updates Fiscal 2027 Outlook

NEW YORK--(BUSINESS WIRE)--RALPH LAUREN REPORTS BETTER THAN EXPECTED FIRST QUARTER FISCAL 2027 RESULTS AND UPDATES FISCAL 2027 OUTLOOK...
-

GAMCO Investors UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: GAMCO Investors, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  ...
-

Douglas Elliman Inc. to Host Second Quarter 2026 Results Conference Call

MIAMI--(BUSINESS WIRE)--Douglas Elliman Inc. (NYSE: DOUG) will conduct a conference call and webcast to discuss its second quarter 2026 results on Friday, August 7, 2026 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://join.eventcastplus.com/eventcastplus/douglas-elliman-second-quarter-earnings-call. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on August 7, 2026 through August 21,...
-

Dispatch Bio Announces First Patient Dosed in Phase 1 Study of DISP-10, a Novel Investigational Immunotherapy, in Advanced Gastrointestinal (GI) Cancers

PHILADELPHIA & SAN FRANCISCO--(BUSINESS WIRE)--Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced the first participant has been dosed in a Phase 1 clinical trial evaluating the safety and efficacy of DISP-10 in adult participants with advanced gastrointestinal (GI) cancers, including colorectal cancer, gastric adenocarcinoma, esophageal adenocarcinoma, and gastroesophageal adenocarcinoma. The parti...
-

One Rock Capital Partners Expands Operating Partner Team With Addition of Ross Bushnell

NEW YORK--(BUSINESS WIRE)--One Rock Capital Partners, LLC (“One Rock”), a value-oriented, operationally focused private equity firm, is pleased to announce the addition of Ross Bushnell to its team of Operating Partners. Mr. Bushnell will be responsible for driving post-acquisition value at One Rock’s portfolio companies through strategic growth initiatives focused on the chemicals and process industries. Mr. Bushnell joins One Rock with over 30 years of experience leading domestic and internat...
-

USA TODAY Co. Announces Second Quarter Results & Reiterates Business Outlook

NEW YORK, NY--(BUSINESS WIRE)--USA TODAY Co., Inc. ("USA TODAY Co.", "we", "us", "our", or the "Company") (NYSE: TDAY) today reported its financial results for the second quarter ended June 30, 2026. "The second quarter reflected continued progress against our long-term strategy and reinforced our confidence in reaffirming our full-year outlook. We reduced operating expenses by approximately 8% year-over-year, generated approximately $20 million of free cash flow, an increase of approximately 1...